Artiva Biotherapeutics ARTV
NASDAQ ARTV
$4.07 +0.01 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Artiva Biotherapeutics (ARTV) Liabilities and Shareholders Equity (2023 - 2026)

Updated

Analysis

Artiva Biotherapeutics (ARTV) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Artiva Biotherapeutics 200.70 Mn -118.40 Mn - 342.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 342.98 Mn
Jun 30, 2026 368.63 Mn
Mar 31, 2026 105.96 Mn
Dec 31, 2025 130.94 Mn
Sep 30, 2025 148.86 Mn
Jun 30, 2025 169.39 Mn
Mar 31, 2025 191.26 Mn
Dec 31, 2024 209.58 Mn
Sep 30, 2024 225.60 Mn
Jun 30, 2024 75.91 Mn
Dec 31, 2023 105.11 Mn
API Access

Artiva Biotherapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ARTV&period=max&api_key=YOUR_API_KEY